Intravenous fluid contaminated with Klebsiella oxytoca as a source of sepsis in a preterm newborn: Case report

Beza Eshetu; Mulatu Gashaw; Melkamu Berhane; Alemseged Abdissa; Elizabeth M McClure; Robert L Goldenberg; Lulu M Muhe

doi:10.1016/j.ajic.2018.12.025

Intravenous fluid contaminated with Klebsiella oxytoca as a source of sepsis in a preterm newborn: Case report

Am J Infect Control. 2019 Jul;47(7):840-842. doi: 10.1016/j.ajic.2018.12.025. Epub 2019 Feb 2.

Authors

Beza Eshetu¹, Mulatu Gashaw², Melkamu Berhane³, Alemseged Abdissa², Elizabeth M McClure⁴, Robert L Goldenberg⁵, Lulu M Muhe⁶

Affiliations

¹ Department of Pediatrics and Child Health, Jimma University, Jimma, Ethiopia. Electronic address: [email protected].
² School of Medical Laboratory Sciences, Jimma University, Jimma, Ethiopia.
³ Department of Pediatrics and Child Health, Jimma University, Jimma, Ethiopia.
⁴ Social, Statistical and Environmental Health Sciences, RTI International, Research Triangle Park, NC.
⁵ Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY.
⁶ Department of Pediatrics and Child Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia; Maternal, Newborn, Child Health and Childhood HIV, TB and Malaria, Geneva, Switzerland.

PMID: 30723029
DOI: 10.1016/j.ajic.2018.12.025

Abstract

Advances in neonatal care have led to the increasing survival of smaller and sicker infants, but nosocomial infections continue to be a serious problem, associated with increased mortality rates, immediate and long-term morbidity, prolonged hospital stay, and increased cost of care. We report a case of hospital-acquired sepsis in a preterm baby secondary to Klebsiella oxytoca, resulting from contaminated intravenous fluid.

Keywords: Culture; Disinfectant; Multidrug resistant; Nosocomial infection; Preeclampsia; Preterm infant; Unhygienic.

Publication types

Case Reports

MeSH terms

Administration, Intravenous
Anti-Bacterial Agents / therapeutic use
Cross Infection / diagnosis*
Cross Infection / drug therapy
Cross Infection / etiology
Cross Infection / microbiology
Fluid Therapy / adverse effects*
Humans
Infant, Newborn
Infant, Premature
Klebsiella Infections / diagnosis*
Klebsiella Infections / drug therapy
Klebsiella Infections / etiology
Klebsiella Infections / microbiology
Klebsiella oxytoca / drug effects
Klebsiella oxytoca / isolation & purification
Klebsiella oxytoca / pathogenicity*
Male
Sepsis / diagnosis*
Sepsis / drug therapy
Sepsis / etiology
Sepsis / microbiology

Substances

Anti-Bacterial Agents